@article{ref1,
title="Psychosocial support interventions for improved adherence and retention in ART care  for young people living with HIV (10-24 years): a scoping review",
journal="BMC public health",
year="2020",
author="Okonji, Emeka F. and Mukumbang, Ferdinand C. and Orth, Zaida and Vickerman-Delport, Shelley A. and van Wyk, Brian",
volume="20",
number="1",
pages="e1841-e1841",
abstract="BACKGROUND: Mental health disorders such as high levels of anxiety, isolation,  depression and suicide ideation reported among young people living with HIV  (10-24 years;YPLHIV) contribute significantly to poor medication adherence and  retention in care. While there is evidence supporting the role of psychosocial  support interventions in promoting adherence and retention in antiretroviral  treatment (ART) among adults living with HIV, there is little evidence on the role  of psychosocial support on medication adherence among YPLHIV. This scoping review  was designed to identify and classify the types and effects of psychosocial support  interventions designed to improve adherence and retention in ART among YPLHIV  globally. <br><br>METHOD: We searched six electronic databases (i.e., Scopus, Pubmed and  EBSCOHost (Academic Search Premier, CINAHL, Psycarticles and Medline). Six relevant  articles published between 2011 and 2019 met our inclusion criteria. We extracted  information relevant to the nature and outcomes of the reported interventions using  thematic content analysis informed by the Population, Intervention, comparison,  outcome, and time (PICOT) framework. <br><br>RESULTS: Four distinctive treatment modalities  that focused on improving ART adherence and retention in care were identified:  individual counselling, support groups, family-centered services, and treatment  supporters. <br><br>CONCLUSION: There is a dearth of psychosocial support interventions to  improve adherence and retention in ART amongst adolescents and young adults living  with HIV. Future research and programming should seek to address psychosocial  support interventions or approaches specifically designed to address the needs of  YPLHIV. TRIAL REGISTRATION: PROSPERO: Registration CRD42018105057.<p /> <p>Language: en</p>",
language="en",
issn="1471-2458",
doi="10.1186/s12889-020-09717-y",
url="http://dx.doi.org/10.1186/s12889-020-09717-y"
}